Syndromes Without a Name Bring Labs an Uphill Battle
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
From - Diagnostic Testing & Emerging Technologies
Dermatopathologists are increasingly using molecular testing for diagnosis of skin cancer samples. Yet, this adoption remains more concentrated in…
From - Diagnostic Testing & Emerging Technologies
Hospitals around the nation are seeing high volumes of patients with the flu this season. A new study, published online Jan. 17 in the Journal of the American Geriatrics Society, shows that…